Updated Jul 16, 2026
Mitchell Shawnte is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $952K.
Shawnte Mitchell is associated with Olema Pharmaceuticals, Inc., a biopharmaceutical company focused on developing targeted therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-06 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 233 | $24.69 | $6K |
| 2026-03-06 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 24.8K | $24.25 | $601K |
| 2026-03-06 | OLMA | Olema Pharmaceuticals, Inc. | M — Option exercise | 25.0K | $4.37 | $109K |
| 2026-03-06 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 15.0K | $23.01 | $345K |
| 2026-03-06 | OLMA | Olema Pharmaceuticals, Inc. | M — Option exercise | 15.0K | $4.37 | $66K |
Shawnte Mitchell is associated with Olema Pharmaceuticals, Inc., a biopharmaceutical company focused on developing targeted therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented.…
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($952K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mitchell Shawnte profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.